2017
DOI: 10.21873/anticanres.11723
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Afatinib Treatment in Non-small Cell Lung Cancer Cells

Abstract: Advanced analysis, might be helpful in understanding the mechanisms of relations between tyrosine kinase inhibition of EGFR and HSPA5 in lung cancer cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
(15 reference statements)
0
1
0
Order By: Relevance
“…According to the International Agency for Research on Cancer(IARC) 2012, the incidence of lung cancer ranks first in the incidence of all malignant tumors 1. Non-small cell lung cancer (NSCLC) is the main type of lung cancer, accounting for about 80% of all lung cancer 2. NSCLC is mainly classified into squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, large cell lung cancer, and sarcomatoid carcinoma.…”
Section: Introductionmentioning
confidence: 99%
“…According to the International Agency for Research on Cancer(IARC) 2012, the incidence of lung cancer ranks first in the incidence of all malignant tumors 1. Non-small cell lung cancer (NSCLC) is the main type of lung cancer, accounting for about 80% of all lung cancer 2. NSCLC is mainly classified into squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, large cell lung cancer, and sarcomatoid carcinoma.…”
Section: Introductionmentioning
confidence: 99%